The global nanoparticles market is driven by the growing demand for nanoparticles in various industries, including electronics, healthcare, and energy. Nanoparticles are used in the production of advanced electronic devices, such as smartphones and tablets, and in the development of nanomedicines for the treatment of various diseases. In addition, the increasing adoption of renewable energy sources, such as solar energy, is boosting the demand for nanoparticles in the energy sector, where they are used in the production of high-efficiency solar cells.
However, the Nanoparticles market growth is also hindered by certain factors, such as the high cost of nanoparticles and the potential health and environmental risks associated with their use. The development of new and advanced nanoparticles with improved properties, along with the increasing research and development activities in this field, is expected to create new opportunities for market growth in the coming years.
Prominent Companies in the Nanoparticles Industry:
1. Abraxis Biosciences, Inc.
Founded in 2000, Abraxis Biosciences, Inc. is a biotechnology company headquartered in California, USA. The company is focused on the development and commercialization of innovative medicines, including nanoparticle-based therapeutics. In December 2021, the company announced that the US FDA has granted Breakthrough Therapy designation to its investigational medicine, nab-pancreatic cancer, for the treatment of patients with metastatic pancreatic cancer.
2. Novartis International AG
Founded in 1996, Novartis International AG is a Swiss multinational pharmaceutical company with its headquarters in Basel, Switzerland. The company has a strong presence in the nanoparticles market, with its products including liposomal formulations of drugs, such as Doxil and Myocet. In November 2021, the company announced that it has completed the acquisition of Advanced Accelerator Applications, a company focused on the development of radioligand therapies using nanoparticle technology.
3. Gilead Sciences, Inc.
Founded in 1987, Gilead Sciences, Inc. is a biopharmaceutical company headquartered in California, USA. The company is focused on the development and commercialization of medicines for the treatment of various diseases, including HIV, viral hepatitis, and cancer. Gilead's product portfolio includes nanoparticle-based drugs, such as Veklury, a treatment for COVID-19. In February 2022, the company announced that it has entered into a strategic collaboration with Schrödinger, Inc. to develop new small molecule therapies using computational methods and nanoparticle drug delivery technologies.
4. Johnson & Johnson
Founded in 1886, Johnson & Johnson is an American multinational healthcare company headquartered in New Jersey, USA. The company has a strong presence in the nanoparticles market, with its products including liposomal formulations of drugs, such as Doxil and Abraxane. In October 2021, the company announced that it has entered into a collaboration with NanoSurface Biomedical, a company focused on the development of nanoparticle-based therapies for the treatment of cancer.
5. Sigma-Tau Pharmaceuticals, Inc.
Founded in 1957, Sigma-Tau Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Maryland, USA. The company is focused on the development and commercialization of medicines for the treatment of various diseases, including cancer and metabolic disorders. Sigma-Tau's product portfolio includes nanoparticle-based drugs, such as DepoCyt, a treatment for certain types of leukemia and lymphoma.
6. Malvern Instruments Ltd.
Founded in 1969, Malvern Instruments Ltd. is a British company that develops and manufactures analytical instruments for the characterization of nanoparticles and other materials. The company's products include the Zetasizer range of instruments, which are used for the measurement of particle size and zeta potential of nanoparticles. In November 2021, the company announced that it has launched a new version of its Zetasizer range, which includes new features for the characterization of nanoparticles in complex samples.
7. Horiba Ltd.
Founded in 1945, Horiba Ltd. is a Japanese company that develops and manufactures analytical and scientific instruments, including those for the characterization of nanoparticles. The company's products include the Nanoparticle Tracking Analysis (NTA) range of instruments, which are used for the measurement of particle size and concentration of nanoparticles. In January 2022, the company announced that it has launched a new version of its NTA range, which includes new features for the measurement of extracellular vesicles and other complex particles.
8. Beckman Coulter
Founded in 1935, Beckman Coulter is an American company that develops and manufactures analytical instruments for the characterization of nanoparticles and other materials.
Definition- Nanoparticles are particles with a size range of 1-100 nanometers in at least one dimension. They exhibit unique physical and chemical properties that make them useful in various applications, including electronics, healthcare, and energy.
